Found Review: The Only Provider Here With a Real Medicare Route — And a Fee Structure People Keep Misreading

What Is Found?

Found Health, Inc. operates from Austin, Texas, with a BBB-listed start date of 13 January 2018 — one of the longer records in this market. It is BBB accredited with an A+ rating, and its complaint file shows 83 complaints over three years with 53 closed in the last twelve months.

Its medication range is the broadest we have reviewed. On the GLP-1 side: compounded semaglutide and tirzepatide from $99/month with flat pricing as your dose increases, plus brand-name Wegovy and Zepbound from $650/month, Ozempic and Mounjaro at around $1,100, Saxenda, Victoza and Foundayo. On the non-GLP-1 side, from $49/month: metformin, Contrave, topiramate, Trulicity, Rybelsus and zonisamide. That last list matters — it means a clinician here can genuinely say no to a GLP-1 and still treat you, which is not true at providers whose entire revenue is semaglutide.

Two features are close to unique in this series. Found partners with insurance carriers across all 50 states, and says most members pay less than $30 per clinical visit through insurance. And it runs a Medicare GLP-1 Bridge Programme for ages 65–75 from as little as $50 a month. Medicare's treatment of GLP-1s for weight is one of the biggest unsolved access problems in this space, and Found is the only provider across more than forty reviews here that has built a route through it.

Its FDA disclosure is also carefully worded and unusually accurate: 'Certain GLP-1 medications are only FDA approved to treat conditions other than weight but may be prescribed to help aid in weight loss.' That is a real distinction — Ozempic and Mounjaro are approved for type 2 diabetes, not weight loss — and almost nobody else states it.

Medications, Membership & Pricing

This is the single most important thing to understand before signing up, and it is where almost every complaint against Found originates. The membership fee and the medication cost are separate charges. Independent reporting puts membership at $99–$149/month depending on tier, with medication billed on top — and a BBB complainant describes asking support directly whether GLP-1 medication was included, being told medications were 'prepared by registered pharmacies and shipped directly to your door for free', and then discovering from the provider that medication costs were separate. Another describes being charged $674 for medication 'not included in membership'. Before you pay anything, get a written answer to one question: what is the total monthly amount, membership plus medication, for the specific drug I will be taking?

Compounded, Brand-Name and Off-Label — What's Actually Approved

Found sells both compounded and brand-name products, which gives a genuine choice about regulatory risk — and its brand-name range is the widest here, covering Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Victoza and Foundayo.

Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or manufacturing quality. The brand-name products have been.

Found's own disclosure makes a distinction most competitors ignore, and it is worth understanding: 'Certain GLP-1 medications are only FDA approved to treat conditions other than weight but may be prescribed to help aid in weight loss.' Ozempic and Mounjaro are approved for type 2 diabetes; Wegovy and Zepbound are the same molecules approved for weight management. Prescribing Ozempic for weight loss is legitimate off-label practice, but it is off-label, and knowing that matters for insurance coverage in particular — plans that cover Ozempic for diabetes frequently will not cover it for weight.

The non-GLP-1 line is a real clinical asset rather than a filler. Metformin, Contrave, topiramate and zonisamide all have roles in weight management, and having them available means treatment does not have to be a GLP-1 by default. Each carries its own profile: Contrave combines naltrexone and bupropion, which lowers the seizure threshold and cannot be taken by anyone using opioids; topiramate and zonisamide can cause cognitive slowing and are teratogenic; metformin needs renal function awareness.

The Consultation Process

Eligibility

• •Found treats adults, with medication determined by clinician assessment. Availability varies by state and by insurance plan.
• •The Medicare GLP-1 Bridge Programme serves ages 65–75 for eligible Medicare Part D members — worth asking about specifically, since Medicare coverage of GLP-1s for weight is otherwise very limited.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive.
• •Clinician judgement is required for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy.
• •Contrave contains bupropion, which lowers the seizure threshold and is contraindicated in anyone with a seizure disorder or eating disorder history, and naltrexone, which must not be taken by anyone using opioids and can precipitate acute withdrawal.
• •Topiramate and zonisamide can cause cognitive slowing, tingling and kidney stones, and both carry teratogenic risk — they must not be used in pregnancy.
• •Common GLP-1 side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — usually worst after a dose increase. Less common but serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury.
• •Older patients, who this service specifically targets through its Medicare programme, warrant particular attention to dehydration risk, muscle mass preservation and interactions with existing medication. Discuss protein intake and resistance exercise with the clinical team.

Clinicians, Testing & Pharmacy

Shipping & Support Services

Medication is shipped to members. Shipping delays appear in the complaint record alongside billing issues. Note the confusion documented above — a complainant was told medication ships 'for free', which is true of the shipping and not of the medication.

• •Insurance partnerships with carriers across all 50 states
• •Most members reportedly pay under $30 per clinical visit through insurance
• •Medicare GLP-1 Bridge Programme for ages 65–75 from as little as $50/month
• •The widest medication range in this series — compounded, brand-name and non-GLP-1
• •Non-GLP-1 options from $49/month for patients who cannot use or do not need a GLP-1
• •Flat compounded pricing as your dose increases
• •BBB accredited with an A+ rating, trading since January 2018
• •Resolves complaints once escalated — refunds processed, memberships restored
• •Accurate FDA disclosure distinguishing diabetes-approved from weight-approved GLP-1s
• •Reported member outcomes in the 30–100 lb range over months to years

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Found May Be Best For

• •Anyone aged 65–75 on Medicare Part D — the Bridge Programme is genuinely unusual and worth the enquiry alone
• •People with insurance who want their clinical visits covered rather than paying cash
• •Patients who may need a non-GLP-1 option, where Found's $49 range gives a clinician real alternatives
• •Anyone wanting brand-name Wegovy or Zepbound alongside insurance navigation
• •People who will get the combined membership-plus-medication total in writing before paying

Limitations

• •The fee structure is the whole problem, and it is a communication failure rather than a pricing one. Charging a membership for clinical care and billing medication separately is a perfectly defensible model — WeightWatchers Med+ does the same and says so plainly. What generates Found's complaints is that the headline reads 'compounded GLP-1s starting at $99/month' while a separate membership sits on top, and support has reportedly told at least one customer that medication ships free before the provider corrected it. One question in writing before you pay solves this entirely: what is my total monthly cost, membership and medication combined?
• •The commitment and refund window compound it. A six-month term with a $99 early cancellation fee, and a full refund available only within three days or before your first consultation, gives very little room to discover the cost structure and change your mind. Those two facts interact badly: you may not learn what you are really paying until after the refund window has closed.
• •The cancellation mechanics are the most avoidable failing. Complainants describe an app that hides the billing section with no accessible way to remove a payment card, and losing profile access the moment a membership lapses — which makes fixing a mistaken cancellation harder than making one. Find the billing section on day one.
• •Set against all that, Found earns real credit for the things that are hard to build. Insurance partnerships across 50 states are not a marketing line — they change what a clinical visit costs from a cash rate to under $30. And the Medicare Bridge Programme addresses a genuine access gap: across this entire series, Medicare patients seeking GLP-1 treatment have had essentially nowhere to go. Found is the only provider we have reviewed offering a structured route, and if you are 65 to 75 that alone justifies the call.
• •It also answers its complaints. Eighty-three complaints over three years is not trivial, but the file shows refunds processed and memberships restored, and the BBB has it accredited at A+. That is a materially different company from the several in this series holding F ratings for answering nothing.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Found has built the two things this market most conspicuously lacks. It partners with insurance carriers across all 50 states, so a clinical visit costs most members under $30 rather than a cash rate. And it runs a Medicare GLP-1 Bridge Programme for ages 65–75 from as little as $50 a month — across more than forty provider reviews in this series, Medicare patients seeking GLP-1 treatment have had essentially nowhere to go, and Found is the only service offering a structured route. Add the widest medication range we have seen, including non-GLP-1 options from $49 that let a clinician genuinely decline a GLP-1 and still treat you, and an A+ BBB accreditation held since 2018, and the substance here is real.

The problem is a fee structure the marketing obscures. 'Compounded GLP-1s starting at $99/month' reads as an all-in price. It is not — a membership fee, reported at $99 to $149 a month, sits separately on top, and a BBB complainant describes support telling them medication shipped free before the provider corrected it and a $674 charge landed. Almost every complaint against Found traces back to that gap.

The commitment terms make it worse rather than better. Six months with a $99 early cancellation fee, and a full refund available only within three days or before your first consultation, means the window to change your mind may close before you have discovered what you are actually paying. And complainants describe an app that hides the billing section with no clear way to remove a card — so find it on day one.

We rate Found 3.4 out of 5. Genuinely differentiated where it counts, genuinely confusing where it costs people money, and — importantly — a company that fixes things when you escalate, which its A+ accreditation reflects and which several F-rated competitors in this series do not.

If you are 65 to 75 on Medicare Part D, call them regardless of this rating; that programme has no equivalent here. If you are insured, the visit pricing is worth the enquiry. If you are paying cash anyway, CoreAge Rx at $99/mo all-in with no separate membership is simpler and cheaper. Whatever you do, get the combined monthly total in writing first.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved. Speak to a licensed clinician about whether treatment is appropriate for you before starting, changing or stopping any medication.